BVF INC/IL Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001056807
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q3 2025 · 46 positions · Total reported value $2.47B · Top-10 concentration 58.6% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 34.8% · 5 new · 9 cut · 2 exited
Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q1 2026 → Q2 2026): +26.0% · vs SPY +11.2% · Prev Value $3.14B — last quarter positions weighted by this quarter price moves · ranking
In its Q3 2025 13F filing, BVF INC/IL disclosed 46 equity positions with a combined reported value of $2.47B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 58.6% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.
The largest disclosed positions as of Q3 2025 were KYMR ($311.45M), RVMD ($185.63M), PTGX ($170.12M). By sector, the heaviest allocations are Health Care 89.6%, Materials 0.0%. Versus the prior quarter, allocation shifted toward Other (+4.9pp) and away from Health Care (-4.9pp).
Versus the prior quarter, BVF INC/IL opened 5 new positions, trimmed 9 and fully exited 2, a turnover rate of 34.8% of positions. The portfolio's overlap with the prior quarter was 76% of names.
The largest new positions opened in Q3 2025 were NKTR ($72.64M), ABVX ($47.38M), STOK ($38.94M).
Of the 2 positions fully exited versus the prior quarter, the largest were IONS ($75.60M), VSTM ($14.13M), RAPT ($9.24M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q3 2025)
Insider Transactions (Form 4)
Latest BVF INC/IL buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
| Transaction date | Activity | Security | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-07-14 | U | XOMA Royalty Corp | 772,000 | — | SEC filing |
| 2026-07-14 | U | XOMA Royalty Corp | 412,000 | — | SEC filing |
| 2026-07-14 | U | XOMA Royalty Corp | 2,773,545 | — | SEC filing |
| 2026-07-14 | U | XOMA Royalty Corp | 3,635,758 | — | SEC filing |
| 2026-06-26 | Sell | Kymera Therapeutics, Inc. | 51,858 | $106.50 | SEC filing |
| 2026-06-26 | Sell | Kymera Therapeutics, Inc. | 113,289 | $106.50 | SEC filing |
| 2026-06-26 | Sell | Kymera Therapeutics, Inc. | 627,597 | $106.50 | SEC filing |
| 2026-06-26 | Sell | Kymera Therapeutics, Inc. | 837,914 | $106.50 | SEC filing |
Fund Profile
BVF INC files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 44 positions worth $3.91B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Portfolio Structure
- 44 positions · $3.91B reported value (Q2 2026)
- Top 10 holdings = 65.6% of reported value
- Largest position: RVMD (REVOLUTION MEDICINES INC) at 14.2%
- Average position size: $88.89M
Sector Tilt
- Health Care 91.6%
- Financials 0.1%
- Materials 0.0%
- (classified holdings cover 92% of value)
Quarterly Activity
- Q2 2026: 5 new, 6 added, 9 reduced, 2 exited
- 24 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
5.50M | $311.45M | 12.62% | Hold | |
| 2 |
|
3.97M | $185.63M | 7.53% | Reduce | |
| 3 |
|
2.56M | $170.12M | 6.90% | Reduce | |
| 4 |
|
19.75M | $141.62M | 5.74% | Hold | |
| 5 |
|
1.41M | $135.42M | 5.49% | Add | |
| 6 |
|
8.83M | $126.24M | 5.12% | Hold | |
| 7 |
|
1.50M | $109.62M | 4.44% | Reduce | |
| 8 |
|
2.59M | $99.83M | 4.05% | Hold | |
| 9 |
|
3.20M | $89.71M | 3.64% | Add | |
| 10 |
|
8.62M | $76.26M | 3.09% | Add | |
| 11 |
|
4.02M | $75.54M | 3.06% | Reduce | |
| 12 |
|
1.16M | $72.80M | 2.95% | Add | |
| 13 |
|
1.28M | $72.64M | 2.94% | New | |
| 14 |
|
3.94M | $67.27M | 2.73% | Reduce | |
| 15 |
|
486.76K | $59.12M | 2.40% | Reduce | |
| 16 |
|
19.82M | $57.29M | 2.32% | Hold | |
| 17 |
|
1.57M | $57.19M | 2.32% | Add | |
| 18 |
|
5.30M | $51.85M | 2.10% | Hold | |
| 19 |
|
3.65M | $51.06M | 2.07% | Reduce | |
| 20 |
|
558.03K | $47.38M | 1.92% | New | |
| 21 |
|
5.66M | $41.94M | 1.70% | Hold | |
| 22 |
|
4.63M | $40.23M | 1.63% | Hold | |
| 23 |
|
1.66M | $38.94M | 1.58% | New | |
| 24 |
|
5.75M | $34.10M | 1.38% | Hold | |
| 25 |
|
658.42K | $32.53M | 1.32% | Reduce | |
| 26 |
|
2.74M | $32.14M | 1.30% | Hold | |
| 27 |
|
5.30M | $25.93M | 1.05% | Hold | |
| 28 |
|
7.00M | $21.35M | 0.86% | Hold | |
| 29 |
|
10.33M | $18.19M | 0.74% | Hold | |
| 30 |
|
1.36M | $17.23M | 0.70% | Add | |
| 31 |
|
4.75M | $16.62M | 0.67% | New | |
| 32 |
|
1.39M | $16.50M | 0.67% | Hold | |
| 33 |
|
6.29M | $16.30M | 0.66% | Hold | |
| 34 |
|
5.23M | $9.51M | 0.39% | Hold | |
| 35 |
|
1.92M | $8.85M | 0.36% | New | |
| 36 |
|
2.23M | $7.64M | 0.31% | New | |
| 37 |
|
7.65M | $6.75M | 0.27% | Hold | |
| 38 |
|
802.10K | $6.54M | 0.27% | New | |
| 39 |
|
1.35M | $5.02M | 0.20% | Hold | |
| 40 |
|
686.04K | $3.97M | 0.16% | Hold | |
| 41 |
|
339.55K | $2.58M | 0.10% | Hold | |
| 42 |
|
11.67M | $2.23M | 0.09% | Add | |
| 43 |
|
932.70K | $1.87M | 0.08% | Add | |
| 44 |
|
65.35K | $980.25K | 0.04% | Reduce | |
| 45 |
|
945.40K | $680.69K | 0.03% | Hold | |
| 46 |
|
143.68K | $262.93K | 0.01% | Hold | |
FAQ
What did BVF INC/IL buy in 2025-Q3?
In its 2025-Q3 13F filing, BVF INC/IL reported 46 equity positions worth $2.47B in aggregate; its largest disclosed positions were KYMR ($311.45M), RVMD ($185.63M), PTGX ($170.12M).
How large is BVF INC/IL's portfolio?
BVF INC/IL reported $2.47B of long equity holdings across 46 positions as of 2025-Q3. Top-10 holdings account for 58.6% of reported value.
What is BVF INC/IL's investment style?
HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.